| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,116 |
4,674 |
$1.02M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,013 |
2,863 |
$629K |
| G0378 |
Hospital observation service, per hour |
309 |
280 |
$293K |
| T1015 |
Clinic visit/encounter, all-inclusive |
1,920 |
522 |
$285K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
668 |
618 |
$120K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
410 |
401 |
$89K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
112 |
109 |
$71K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
151 |
144 |
$45K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
918 |
863 |
$38K |
| 80053 |
Comprehensive metabolic panel |
2,473 |
2,163 |
$30K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
129 |
125 |
$25K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
317 |
306 |
$21K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
870 |
770 |
$18K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
319 |
307 |
$17K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
49 |
48 |
$16K |
| 97161 |
|
156 |
143 |
$15K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
687 |
632 |
$15K |
| 71046 |
Radiologic examination, chest; 2 views |
476 |
462 |
$13K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,365 |
1,194 |
$13K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
104 |
103 |
$12K |
| 70450 |
Computed tomography, head or brain; without contrast material |
355 |
345 |
$11K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
46 |
46 |
$10K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
55 |
54 |
$10K |
| 87631 |
|
116 |
113 |
$9K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
13 |
13 |
$9K |
| 76830 |
Ultrasound, transvaginal |
45 |
44 |
$9K |
| 73630 |
|
86 |
83 |
$8K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,028 |
2,578 |
$8K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
777 |
743 |
$8K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
129 |
125 |
$8K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
257 |
244 |
$7K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
870 |
781 |
$7K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
12 |
12 |
$6K |
| 71045 |
Radiologic examination, chest; single view |
559 |
526 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
590 |
526 |
$5K |
| 94060 |
|
13 |
12 |
$3K |
| 73610 |
|
45 |
45 |
$3K |
| 76642 |
|
14 |
14 |
$3K |
| 0001A |
|
90 |
90 |
$3K |
| 0002A |
|
83 |
83 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
706 |
638 |
$2K |
| 84484 |
|
922 |
774 |
$2K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
19 |
17 |
$2K |
| 94729 |
|
13 |
12 |
$2K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
113 |
27 |
$2K |
| 93922 |
|
13 |
12 |
$2K |
| 85610 |
|
524 |
486 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
56 |
55 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
277 |
267 |
$2K |
| 85027 |
|
95 |
91 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
425 |
409 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,516 |
1,318 |
$2K |
| 94726 |
|
13 |
12 |
$1K |
| 73030 |
|
26 |
25 |
$1K |
| 85730 |
|
281 |
273 |
$1K |
| 73130 |
|
16 |
15 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
428 |
373 |
$1K |
| 83880 |
|
199 |
186 |
$1K |
| 83690 |
|
694 |
641 |
$929.72 |
| 93971 |
|
12 |
12 |
$896.82 |
| 72100 |
|
14 |
13 |
$856.67 |
| 82550 |
|
459 |
422 |
$753.91 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
33 |
31 |
$748.70 |
| 84703 |
|
83 |
73 |
$745.29 |
| 82248 |
|
329 |
316 |
$599.74 |
| 81025 |
|
649 |
619 |
$588.85 |
| 73110 |
|
12 |
12 |
$567.87 |
| 83735 |
|
368 |
314 |
$563.87 |
| 81001 |
|
726 |
687 |
$563.48 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
56 |
55 |
$507.41 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
28 |
25 |
$498.60 |
| J3490 |
Unclassified drugs |
463 |
379 |
$433.55 |
| 94760 |
|
167 |
131 |
$426.85 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
96 |
80 |
$353.42 |
| 83605 |
|
164 |
152 |
$352.76 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
36 |
12 |
$332.73 |
| 81003 |
|
405 |
387 |
$283.53 |
| 36415 |
Collection of venous blood by venipuncture |
216 |
204 |
$280.48 |
| 82962 |
|
361 |
223 |
$279.93 |
| 80061 |
Lipid panel |
27 |
27 |
$260.52 |
| 87040 |
|
45 |
39 |
$246.86 |
| 84145 |
|
61 |
55 |
$244.31 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
595 |
560 |
$236.15 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
52 |
47 |
$234.56 |
| 84702 |
|
37 |
33 |
$225.94 |
| 87077 |
|
62 |
61 |
$221.07 |
| 86900 |
|
68 |
66 |
$215.51 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
40 |
40 |
$191.72 |
| 96376 |
|
76 |
58 |
$188.94 |
| 85379 |
|
70 |
67 |
$180.20 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
505 |
445 |
$138.95 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
89 |
79 |
$133.10 |
| 86901 |
|
55 |
54 |
$99.28 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
59 |
56 |
$95.44 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
18 |
12 |
$68.80 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
129 |
118 |
$65.28 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
57 |
44 |
$64.93 |
| J2060 |
Injection, lorazepam, 2 mg |
184 |
155 |
$59.16 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
114 |
103 |
$43.42 |
| J2704 |
Injection, propofol, 10 mg |
43 |
41 |
$36.64 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
74 |
64 |
$34.10 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
91 |
83 |
$29.52 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
81 |
74 |
$25.83 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
12 |
12 |
$15.84 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
69 |
69 |
$15.40 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
31 |
29 |
$3.66 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
16 |
14 |
$3.14 |
| J7050 |
Infusion, normal saline solution, 250 cc |
63 |
52 |
$2.56 |
| 00000 |
|
649 |
287 |
$0.00 |